← Back to Clinical Trials
Recruiting NCT05640700

Vaginal Microbiome and HPV Pre-malignant and Cervical Dysplasia

Trial Parameters

Condition Human Papilloma Virus
Sponsor Hadassah Medical Organization
Study Type OBSERVATIONAL
Phase N/A
Enrollment 90
Sex FEMALE
Min Age 25 Years
Max Age 70 Years
Start Date 2022-11-09
Completion 2025-12-30

Brief Summary

In this study, the investigators will prospectively collect, analyze and integrate information regarding vaginal microbiome composition and HPV presence in women with cervical pathologies (high-grade CIN and CC) and controls, to construct a large dataset from patients with pre-cancerous cervical lesions and healthy women, to evaluate the personalized contribution of the vaginal microbiome to the CIN-CC sequence.

Eligibility Criteria

Inclusion Criteria: * Age 25-70 * Attended the clinic for a Pap smear or colposcopy Exclusion Criteria: * Patient does not approve sample collection * Usage of antibiotics in the month prior to clinic visit * Usage of any vaginal preparation or medication in the week prior to sample collection (anti-fungal, spermicides, lubricant etc.) * Menstruation * Pregnancy

Related Trials